EXO Stock Analysis: Exor | AS
Farm & Heavy Construction Machinery | AS, Netherlands | Market Cap: 22.021m EUR | 12M Return: -20% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 13.0M
Qual. Beats: 0
Rev. Trend: -49.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 3.9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Exor N.V. is a Dutch-domiciled holding company, classified as a large-cap consumer discretionary stock under GICS automobile manufacturers, though it operates as a diversified investment vehicle with controlling stakes across multiple industries. The companys portfolio spans automotive (Ferrari, Stellantis brands including Fiat, Jeep, Alfa Romeo, Maserati), agricultural and construction equipment (CNH Industrial), health technology (Philips), commercial vehicles, powertrain technologies, and media (The Economist). It also holds interests in luxury goods, professional football (Juventus FC), hospitals, and clean energy solutions.
Founded in 1899 and headquartered in Amsterdam, Exor is controlled by the Agnelli family through its parent Giovanni Agnelli B.V., reflecting over a century of family-led investment stewardship. The Agnelli familys involvement traces back to the original founding of Fiat, and Exors structure follows the European holding company model, using the Netherlands as its corporate base for tax and governance purposes. The business model centers on long-term capital allocation across operating subsidiaries rather than direct manufacturing.
- Ferrari deliveries and order book drive luxury segment margins
- Stellantis earnings swing auto mass-market revenue exposure
- CNH farm equipment demand weakens on commodity cycle
| Net Income: -3.79b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 8.28 > 1.0 |
| NWC/Revenue: 298.6% < 20% (prev -4.86%; Δ 303.4% < -1%) |
| CFO/TA 0.08 > 3% & CFO 2.86b > Net Income -3.79b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 16.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (207.6m) vs 12m ago -7.96% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 2.72% > 50% (prev 36.26%; Δ -33.54% > 0%) |
| Interest Coverage Ratio: -36.95 > 6 (EBIT TTM -3.69b / Interest Expense TTM 100.0m) |
| A: 0.09 (Total Current Assets 3.31b - Total Current Liabilities 196.0m) / Total Assets 34.1b |
| B: 0.90 (Retained Earnings 30.7b / Total Assets 34.1b) |
| C: -0.10 (EBIT TTM -3.69b / Avg Total Assets 38.3b) |
| D: 7.81 (Book Value of Equity 30.4b / Total Liabilities 3.89b) |
| Altman-Z'' = 11.09 = AAA |
As of July 08, 2026, the stock is trading at EUR 69.35 with a total of 190,387 shares traded. Over the past week, the price has changed by +3.51%, over one month by +4.52%, over three months by +5.36% and over the past year by -19.98%.
Current recommended Stop Loss: 67.30 (which is 3% or 1.5 ATR below the current price).
Exor has no consensus analysts rating.
P/S = 1.7692
P/B = 0.4067
Revenue TTM = 1.04b EUR
EBIT TTM = -3.69b EUR
EBITDA TTM = -3.69b EUR
Long Term Debt = 3.47b EUR (estimated: total debt 3.67b - short term 196.0m)
Short Term Debt = 196.0m EUR (from shortTermDebt, last quarter)
Debt = 3.67b EUR (from shortLongTermDebtTotal, last quarter) + Leases 2.00m
Net Debt = 2.28b EUR (calculated: Debt 3.67b - CCE 1.39b)
Enterprise Value = 24.3b EUR (22.0b + Debt 3.67b - CCE 1.39b)
Interest Coverage Ratio = -36.95 (Ebit TTM -3.69b / Interest Expense TTM 100.0m)
EV/FCF = 8.49x (Enterprise Value 24.3b / FCF TTM 2.86b)
FCF Yield = 11.78% (FCF TTM 2.86b / Enterprise Value 24.3b)
FCF Margin = 274.8% (FCF TTM 2.86b / Revenue TTM 1.04b)
Net Margin = -364.0% (Net Income TTM -3.79b / Revenue TTM 1.04b)
Gross Margin = unknown ((Revenue TTM 1.04b - Cost of Revenue TTM 20.0m) / Revenue TTM)
Tobins Q-Ratio = 0.71 (Enterprise Value 24.3b / Total Assets 34.1b)
Interest Expense / Debt = 2.73% (Interest Expense 100.0m / Debt 3.67b)
Taxrate = 25.0% (non-US conservative default 25%)
NOPAT = -2.77b (EBIT -3.69b * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 16.87 (Total Current Assets 3.31b / Total Current Liabilities 196.0m)
Debt / Equity = 0.12 (Debt 3.67b / totalStockholderEquity, last quarter 30.4b)
Debt / EBITDA = -0.62 (negative EBITDA) (Net Debt 2.28b / EBITDA -3.69b)
Debt / FCF = 0.80 (Net Debt 2.28b / FCF TTM 2.86b)
Total Stockholder Equity = 35.8b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.90% (Net Income -3.79b / Total Assets 34.1b)
RoE = -10.59% (Net Income TTM -3.79b / Total Stockholder Equity 35.8b)
RoCE = -9.40% (EBIT -3.69b / Capital Employed (Equity 35.8b + L.T.Debt 3.47b))
RoIC = -8.13% (negative operating profit) (NOPAT -2.77b / Invested Capital 34.1b)
WACC = 7.36% (E(22.0b)/V(25.7b) * Re(8.25%) + D(3.67b)/V(25.7b) * Rd(2.73%) * (1-Tc(0.25)))
Discount Rate = 8.25% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -88.66 | Cagr: -5.29%
[DCF] Terminal Value 77.97% ; FCFF base≈1.74b ; Y1≈1.99b ; Y5≈2.93b
[DCF] Fair Price = 206.7 (EV 44.1b - Net Debt 2.28b = Equity 41.8b / Shares 202.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.27 | # QB: 0
Revenue Correlation: -49.78 | Revenue CAGR: -23.83% | SUE: 0.07 | # QB: 0
EPS current Year (2026-12-31): EPS=2.21 | Chg30d=+163.29% | Revisions=+25% | GrowthEPS=-10.5% | GrowthRev=+0.0%
EPS next Year (2027-12-31): EPS=1.26 | Chg30d=-47.82% | Revisions=-25% | GrowthEPS=-42.8% | GrowthRev=+0.0%